- Home
- MAIA vs NMTC Comparison
MAIA vs NMTC Comparison
Compare MAIA & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- NMTC
- Stock Information
- Founded
- MAIA 2018
- NMTC 2009
- Country
- MAIA United States
- NMTC United States
- Employees
- MAIA N/A
- NMTC N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- NMTC Medical/Dental Instruments
- Sector
- MAIA Health Care
- NMTC Health Care
- Exchange
- MAIA Nasdaq
- NMTC Nasdaq
- Market Cap
- MAIA 44.9M
- NMTC 45.0M
- IPO Year
- MAIA 2022
- NMTC N/A
- Fundamental
- Price
- MAIA $1.11
- NMTC $0.69
- Analyst Decision
- MAIA
- NMTC Strong Buy
- Analyst Count
- MAIA 0
- NMTC 2
- Target Price
- MAIA N/A
- NMTC $2.23
- AVG Volume (30 Days)
- MAIA 747.3K
- NMTC 305.0K
- Earning Date
- MAIA 11-07-2025
- NMTC 12-16-2025
- Dividend Yield
- MAIA N/A
- NMTC N/A
- EPS Growth
- MAIA N/A
- NMTC N/A
- EPS
- MAIA N/A
- NMTC N/A
- Revenue
- MAIA N/A
- NMTC $6,629,051.00
- Revenue This Year
- MAIA N/A
- NMTC $162.84
- Revenue Next Year
- MAIA N/A
- NMTC $26.51
- P/E Ratio
- MAIA N/A
- NMTC N/A
- Revenue Growth
- MAIA N/A
- NMTC 69.00
- 52 Week Low
- MAIA $1.05
- NMTC $0.40
- 52 Week High
- MAIA $3.48
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- MAIA 34.52
- NMTC 30.77
- Support Level
- MAIA $1.05
- NMTC $0.70
- Resistance Level
- MAIA $1.35
- NMTC $0.76
- Average True Range (ATR)
- MAIA 0.10
- NMTC 0.05
- MACD
- MAIA -0.03
- NMTC -0.01
- Stochastic Oscillator
- MAIA 12.85
- NMTC 16.55
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.